A Clinical Study of 677 Cases of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

DOI Web Site 4 Citations 21 References

Bibliographic Information

Other Title
  • 突発性難聴６７７例の重症度別治療成績
  • 臨床 突発性難聴677例の重症度別治療成績
  • リンショウ トッパツセイ ナンチョウ 677レイ ノ ジュウショウド ベツ チリョウ セイセキ

Search this article

Description

We studied 677 cases with idiopathic sudden sensorineural hearing loss (ISSNHL) treated with at least intravenous batroxobin, oral betamethasone, and hyperbaric oxygen therapy. The 677 patients received at least intravenous batroxobin from 2005 to 2008.<br> Overall “cure” was 30.7%, 44.2% for Grade 1, 34.4% for Grade 2, 32.2% for Grade 3, and 8.1% for Grade 4. Within the twelve days between onset and treatment start, “cure” was 38.2%. Hearing loss severity and the duration both significantly influenced hearing recovery.<br>

Journal

Citations (4)*help

See more

References(21)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top